Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide in High Output Stoma
NCT02354768Phase 3Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Oct 2015
- Primary completion
- Dec 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lanreotide in High output stoma (HOS), sponsored by Strasbourg University Hospital. Started Oct 2015; status: terminated.
02
Drugs
lanreotide
03
Conditions
High output stoma (HOS)
Beyond the preview
Go deeper on NCT02354768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02354768.